FolioLanternBeta
COGTCogent Biosciences, Inc.

Cole Pinnow

Chief Commercial Officer at Cogent Biosciences, Inc., as of Dec 19, 2025No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
217K
shares held after the latest filing, Cogent Biosciences, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Last filing: Dec 19, 2025. Most recent purchase on record: Jan 14, 2025.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Cogent Biosciences, Inc. (COGT)Chief Commercial OfficerMay 29, 2024Dec 19, 2025

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.